Billing Codes
CPT 52204: Cystourethroscopy with Biopsy
CPT-52000-DIAGNOSTIC-CYSTOURETHROSCOPY-BLADDER-URETHRACPT 52000: Diagnostic Cystourethroscopy of Bladder and Urethra
CPT-52356-URETEROSCOPY-LITHOTRIPSY-WITH-URETERAL-STENTCPT 52356: Ureteroscopy with Lithotripsy and Indwelling Ureteral Stent
CPT-51720-INTRAVESICAL-INSTILLATION-ANTICARCINOGENIC-AGENTCPT 51720: Intravesical Instillation of Anticarcinogenic Agent
CPT-51784-ANAL-OR-URETHRAL-SPHINCTER-ELECTRICAL-ACTIVITY-TESTINGCPT 51784: Anal or Urethral Sphincter Electrical Activity Testing
CPT-52332-CYSTOURETHROSCOPY-URETERAL-STENT-PLACEMENTCPT 52332: Cystourethroscopy with Ureteral Stent Placement
CPT-51798-BLADDER-POST-VOID-RESIDUAL-ULTRASOUNDCPT 51798: Bladder Ultrasound to Measure Post‑Void Residual
CPT-52500-CYSTOURETHROSCOPY-TRANSURETHRAL-EXCISION-BLADDER-NECKCPT 52500: Cystourethroscopy with Transurethral Excision of Bladder Neck
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.